PHYTORECEPTORS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 1.9% 1.6% 3.0% 2.6%  
Credit score (0-100)  70 69 73 57 60  
Credit rating  A A A BBB BBB  
Credit limit (kDKK)  1.1 1.6 8.8 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  5,257 3,920 3,628 4,227 3,158  
EBITDA  4,816 2,946 2,743 3,321 2,267  
EBIT  4,802 2,919 2,632 3,266 2,236  
Pre-tax profit (PTP)  4,841.6 2,883.8 2,560.6 3,206.5 2,332.2  
Net earnings  3,768.5 2,234.8 1,994.3 2,499.3 1,817.4  
Pre-tax profit without non-rec. items  4,842 2,884 2,561 3,207 2,332  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  256 261 150 95.9 111  
Shareholders equity total  4,269 3,235 2,994 3,499 3,317  
Interest-bearing liabilities  5,147 4,598 3,542 8,272 6,728  
Balance sheet total (assets)  17,812 13,808 10,899 23,431 22,398  

Net Debt  -2,875 -1,338 905 -842 -5,084  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,257 3,920 3,628 4,227 3,158  
Gross profit growth  -44.9% -25.4% -7.5% 16.5% -25.3%  
Employees  2 1 1 1 1  
Employee growth %  0.0% -50.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  17,812 13,808 10,899 23,431 22,398  
Balance sheet change%  23.2% -22.5% -21.1% 115.0% -4.4%  
Added value  4,815.8 2,946.4 2,743.1 3,376.9 2,267.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  243 -22 -222 -109 -16  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  91.4% 74.5% 72.6% 77.3% 70.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  30.1% 18.7% 21.3% 19.0% 10.7%  
ROI %  64.5% 34.2% 36.5% 35.6% 22.4%  
ROE %  76.4% 59.6% 64.0% 77.0% 53.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  24.0% 23.4% 27.5% 14.9% 14.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -59.7% -45.4% 33.0% -25.4% -224.2%  
Gearing %  120.6% 142.2% 118.3% 236.4% 202.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.3% 1.4% 1.8% 1.0% 1.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 1.0 1.1 1.1 1.1  
Current Ratio  1.3 1.3 1.4 1.2 1.2  
Cash and cash equivalent  8,022.4 5,935.9 2,636.8 9,114.6 11,811.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  4,020.6 2,991.5 2,853.1 3,388.6 3,213.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  2,408 2,946 2,743 3,377 2,267  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  2,408 2,946 2,743 3,321 2,267  
EBIT / employee  2,401 2,919 2,632 3,266 2,236  
Net earnings / employee  1,884 2,235 1,994 2,499 1,817